At 77 degrees Fahrenheit (25 Celsius), the standard controlled room temperature, most formulations remain stable for 28 to 60 days
Diarrhea affects 24% of users, usually appearing in transient episodes lasting 1-3 weeks rather than as a constant issue
These include nausea, vomiting, diarrhea, constipation, belching, and heartburn
A Guide to Storing GLP-1 Medications: Wegovy, Zepbound, and Compounded Alternatives Starting a GLP-1 medication journey is a significant commitment to your health
Retatrutide dose compared to tirzepatide and semaglutide Comparison is inevitable
By application analysis In 2024, the type 2 diabetes mellitus segment led the GLP-1 receptor agonist market due to the high incidence of the disease and the major efficacy of these drugs in controlling blood sugar levels and encouraging weight loss, contributing majorly to the expansion of the type 2 diabetes mellitus segment